AI summary · may contain errors
SARS-CoV-2 and chikungunya virus macrodomain inhibitors repeatedly converge on adenine-anchored scaffolds, defining a structurally confined druggable corridor limited by a permeability–potency tradeoff.
American Society for Pharmacology and Experimental Therapeutics · Pharmacology & Drug Discovery · ISSN 0031-6997, 1521-0081
Rebuilt
Newest first · last 60 days
AI summary · may contain errors
SARS-CoV-2 and chikungunya virus macrodomain inhibitors repeatedly converge on adenine-anchored scaffolds, defining a structurally confined druggable corridor limited by a permeability–potency tradeoff.
Journals this month
Topics moving, week to 17 Nov 2026
By field